Levofloxacin-Amoxicillin/Clavulanate-Rabeprazole versus a Standard Seven-Day Triple Therapy for Eradication of Helicobacter pylori Infection

Table 3

Comparison of eradication rate and subgroup analysis.

	Perprotocol analysis				Intention-to-treat analysis
	LAcR, 𝑛 (%)	CAR, 𝑛 (%)	𝑃 value	Odd ratio (95% CI)	LAcR, 𝑛 (%)	CAR, 𝑛 (%)	𝑃 value	Odd ratio (95% CI)
All	55 (80.9)	42 (61.8)	0.014*	2.619; (1.20∼5.70)	57 (78.1)	42 (57.5)	0.008*	2.629 (1.28∼5.42)
Age
<60 years old	37 (75.5)	31 (72.1)	0.710	1.194 (0.47~3.03)	37 (72.5)	31 (66.0)	0.479	1.364 (0.58~3.23)
≧60 years old	20 (95.2)	11 (42.3)	0.000*	27.273 (3.17~235)	20 (90.9)	11 (42.3)	0.000*	13.636 (2.62~70.91)
Gender
Male	30 (81.1)	20 (64.5)	0.123	2.357 (0.78~7.11)	30 (78.9)	20 (60.6)	0.091	2.438 (0.86~6.94)
Female	25 (80.6)	22 (59.5)	0.060	2.841 (0.94~8.59)	27 (77.1)	22 (55.0)	0.044*	2.761 (1.01~7.55)
Resident area
Urban	21 (77.8)	16 (76.2)	0.748	1.094 (0.28~4.23)	22 (73.3)	16 (66.7)	0.594	1.375 (0.43~4.44)
Rural	34 (82.9)	26 (55.3)	0.006*	3.923 (1.45~10.62)	35 (81.4)	26 (53.1)	0.004*	3.870 (1.50~10.02)
Endoscopic finding
With peptic ulcer	22 (75.9)	22 (66.7)	0.426	1.571 (0.51~4.80)	22 (73.3)	22 (62.9)	0.368	1.625 (0.56~4.69)
Without peptic ulcer	33 (84.6)	20 (57.1)	0.009*	4.125 (1.38~12.36)	35 (81.4)	20 (52.6)	0.006*	3.938 (1.45~10.68)

^∗𝑃<0.05.